Does Dr. MEHRAN ABOLBASHARI have financial conflicts of interest?

Dr. MEHRAN ABOLBASHARI (M.D.) has received a total of $449 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $449 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MEHRAN ABOLBASHARI?

According to CMS Open Payments data, Dr. MEHRAN ABOLBASHARI received funding from BIOSENSE WEBSTER ($145), NOVARTIS PHARMACEUTICALS CORPORATION ($82), and ABBOTT LABORATORIES ($53).

Does Dr. MEHRAN ABOLBASHARI receive research grants or speaking fees?

Dr. MEHRAN ABOLBASHARI has received $449 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MEHRAN ABOLBASHARI

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Cardiovascular Disease

Practice Location: EL PASO, TX 79905

NPI Number: 1144633272

LIFETIME INDUSTRY VALUE

$449

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABOLBASHARI is a verified Internal Medicine, Cardiovascular Disease practitioner based in EL PASO, TX.

Between 2021 and 2024, Dr. ABOLBASHARI had an overall industry promotional and research financial footprint of $449 as recorded in the federal CMS Open Payments database.

$449 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABOLBASHARI's primary funding source is BIOSENSE WEBSTER, which accounts for $145 (representing 32.4% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BIOSENSE WEBSTER

Rank 1

$145

32.4%

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 2

$82

18.3%

ABBOTT LABORATORIES

Rank 3

$53

11.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.